جست‌وجوی استاد و پژوهشگر

Vibeke Moeمشاهده پروفایل

استاد

• Infant and Toddler Mental Health
• Developmental Psychopathology
• Parental Mental Health During Pregnancy and Postpartum
• +۶ مورد دیگر

Vibeke Moe is a Professor at the Department of Psychology, University of Oslo , specializing in infant and toddler mental health. Her work focuses on developmental psychopathology, parental mental health during pregnancy and postpartum, and the impact of substance abuse and mental health disorders on parent-infant interactions. Project leader for the population-based Little in Norway (LiN) study , a prospective longitudinal cohort examining infant vulnerability and plasticity from pregnancy to 18 months postpartum. Collaborates with international institutions like the University of Otago (New Zealand) and University of Michigan (USA), and national entities including the Norwegian Institute of Public Health and University of Tromsø. Academic Background : 2007: Specialist in Clinical Child and Adolescent Psychology 2002: Dr. Psychol., University of Oslo 1994: Cand. Psychol., University of Oslo 1985: Cand. Mag., Faculty of Social Sciences, University of Oslo Research Themes : Her research integrates biological and social factors to understand developmental pathways in children exposed to prenatal risks, with emphasis on neurocognitive outcomes, attachment theory, and parent-infant interaction patterns. Current projects include longitudinal follow-ups of children prenatally exposed to opioids and polydrug use, and intergenerational transmission of adversity in perinatal psychotherapy. Publications : Recent work addresses parental attachment styles and depressive symptoms in the transition to parenthood, regulatory problems in early childhood, and intergenerational relationship dynamics in therapeutic contexts. Articles span journals like Journal of Marriage and Family , Infant Mental Health Journal , and BMC Psychiatry . Awards and Leadership : Recipient of the 2015 Teaching Prize at the University of Oslo, former President of the Nordic Association for Infant Mental Health (2008–2012), and current board member with international responsibilities. She has supervised 7 PhD candidates since 2006.

• Posttraumatic Stress Disorder
• Desensitization
• Borderline Personality Disorder
• +۵ مورد دیگر

Marlies Marissen serves as Associate Professor in the Department of Clinical Psychology at Erasmus School of Social and Behavioural Sciences, Erasmus University Rotterdam. Her academic career centers on clinical psychopathology with emphasis on personality disorders and trauma-related conditions, evidenced by 15 research outputs including high-impact publications in Psychiatry Research and Journal of Behavior Therapy and Experimental Psychiatry . Her research portfolio reveals deep specialization in Borderline Personality Disorder , Narcissistic Personality Disorder , and Posttraumatic Stress Disorder (PTSD) , with significant contributions to understanding Eye Movement Desensitization and Reprocessing (EMDR) applications. Key investigations include emotion recognition deficits in narcissism, masked self-esteem phenomena, anhedonia-impulsivity relationships in BPD, and innovative integration of EMDR therapy at early treatment stages for comorbid PTSD-BPD cases. Her work consistently bridges clinical observation with empirical validation through controlled studies. Publication trends (2012-2023) demonstrate methodological evolution from foundational symptom analysis toward treatment-intervention research, particularly the 2023 pilot study exploring EMDR timing in BPD treatment protocols. Her articles generate substantial academic engagement, with the 2016 self-esteem study accumulating 16 Scopus citations and extraordinary social media traction (185,891 interactions), while the 2012 emotion recognition paper received 68 citations and news coverage. No scientific awards were documented in the source material. Though specific student supervision details are absent, her collaborative publication pattern (frequent co-authorship with Slotema, Franken, Deen, and van den Berg) suggests active mentorship within Erasmus University's clinical psychology research ecosystem. Grant funding information remains unspecified, though her sustained output implies successful research financing. Dr. Marissen operates within Erasmus University's clinical psychology research network, contributing to the institution's fingerprint in personality disorder psychopathology. Her work aligns with the university's clinical neuroscience initiatives, particularly through collaborations examining neurocognitive aspects of narcissism and borderline pathology.

Dejan Stosicمشاهده پروفایل

استاد

• Semantics of space
• Syntax and semantics of prepositions
• Expression of manner in language
• +۷ مورد دیگر

Dejan Stosic is a Professor in the Department of Language Sciences at the University of Toulouse Jean Jaurès, where he has been employed since 2003, first as Lecturer (2013-2022) and currently as University Professor (since 2022). He is a member of the CLLE Laboratory (Cognition, Languages, Language, Ergonomie), a joint research unit (UMR 5263) of the CNRS. His academic career spans multiple institutions, including previous positions at the University of Artois. Stosic's research focuses at the interface of semantics and syntax, with specializations in spatial semantics, prepositional semantics, expression of manner, nominal semantics, and lexical/grammatical polysemy. His work primarily examines French, with significant comparative components involving Serbian and English. Methodologically, he combines introspection with corpus analysis in his linguistic investigations. His most recent publications (2023-2024) demonstrate a continued focus on complex prepositions in French, polysemy patterns, spatial-temporal mappings, and the expression of manner across languages. These works reveal consistent research trajectories examining how spatial concepts structure temporal domains and how complex prepositional constructions evolve across European languages. Stosic is actively involved in multiple research projects including the ANR DIVITAL project (2021-2025) focused on increasing the digital vitality of regional French languages, and the SALTA project examining spatial asymmetries across languages. He regularly organizes academic events such as the PrETrELa event (2024) on written press and language study, and the MoCo Workshop on Motion & Cognition. His scholarly contributions include several significant books such as 'Complex Adpositions in European Languages' (2020), 'The Semantics of Dynamic Space in French' (2019), and 'Les prépositions complexes en français. Théories, descriptions, applications' (2023), establishing him as a leading expert in prepositional semantics and complex adpositions across European languages.

Ze Wangمشاهده پروفایل

استاد

• Magnetic Resonance Imaging (MRI)
• Neuroimaging Signal Processing
• Alzheimer's Disease Research
• +۳ مورد دیگر

Ze Wang, PhD is a tenured Professor in the Department of Diagnostic Radiology and Nuclear Medicine at University of Maryland School of Medicine . He leads the Imaging Computing Lab (ICL) and serves as a Principal Investigator at the Center for Advanced Imaging Research . With a PhD in Biomedical Engineering from Shanghai Jiao Tong University (2003) and postdoctoral training at University of Pennsylvania , Dr. Wang has developed groundbreaking tools like ASLtbx , SVR-LSM , and BENtbx for ASL MRI, lesion-symptom mapping, and brain entropy analysis.

• Neurosurgery
• Epilepsy surgery
• Pediatric neurosurgery
• +۷ مورد دیگر

Peter Christian Warnke, MD is a Professor of Neurological Surgery at the University of Chicago's Pritzker School of Medicine. An internationally renowned neurosurgeon, Dr. Warnke has performed more than 7,000 stereotactic surgeries and over 3,000 brain tumor surgeries throughout his distinguished career. He directs the pediatric and adult epilepsy surgery program within the Comprehensive Epilepsy Center and the MRI-Guided Laser Ablation Program for epilepsy and tumors at the University of Chicago, where he has performed more than 400 laser surgeries. Internationally recognized expertise in pediatric neurosurgery, brain tumor surgery (neurooncology), and movement and epilepsy surgery Director of SLATE, NAUTILUS and RESPONSE trials in epilepsy surgery Associate Editor of the Journal of Neurology, Neurosurgery and Psychiatry (impact factor 13.65) Performed first laser hemispherectomy for drug-resistant epilepsy in Illinois and second worldwide First neurosurgeon in Chicago to use directional deep brain stimulation Dr. Warnke's research focuses on developing biological and minimally invasive treatments for epilepsy, movement disorders and brain tumors using functional imaging and fiber tracking. His work particularly emphasizes Brain-Computer Interface for the motor and sensory cortex, mechanisms of memory formation, and the effect of laser energy on tumor permeability, blood flow and extracellular space in brain tumors. His research is collaboratively funded by 4 NIH grants including the Brain Initiative. Analysis of Dr. Warnke's recent publications reveals a strong focus on advancing intracortical microstimulation techniques for restoring sensory function, particularly tactile perception. His work bridges neurosurgery, neuroscience, and neuroengineering with significant contributions to epilepsy surgery techniques, deep brain stimulation applications, and innovative laser ablation procedures. Much of his recent work involves collaborative research on brain-computer interfaces, with emphasis on creating more natural sensory feedback for neuroprosthetic applications. Dr. Warnke directs multiple clinical trials investigating laser ablation and closed loop brain stimulation as minimally invasive alternatives to open surgery for epilepsy treatment. He also leads research exploring new biological treatments for epilepsy using cell transplants to silence epileptic areas (Neurona Trial). His work on psychiatric neurosurgery, particularly for obsessive compulsive disorder using interstitial laser techniques, represents another significant research frontier. Dr. Warnke has established and directs specialized programs including the SLATE, NAUTILUS and RESPONSE trials for epilepsy surgery. His MRI-Guided Laser Ablation Program has performed over 400 laser surgeries at the University of Chicago. He collaborates extensively with the ACID research group in the Department of Psychiatry for psychiatric neurosurgery applications. His research on Brain-Computer Interface involves collaboration with multiple institutions to develop more effective neural prosthetics with natural sensory feedback.

Toomas Erik Anijärvمشاهده پروفایل

پژوهشگر

• Medical imaging science
• Neurology
• Geriatrics
• +۷ مورد دیگر

Toomas Erik Anijärv is a Doctoral student and Researcher at Lund University's medical faculty, specializing in clinical memory research through affiliations with MultiPark (a multidisciplinary Parkinson's disease research center). His work bridges neuroscience, neurology, and geriatrics with emphasis on EEG-based neurophysiological analysis. His primary research domains include: Alzheimer's and Parkinson's disease mechanisms through neuroimaging EEG spectral analysis of healthy aging and cognitive decline Neurophysiological impacts of cyberbullying on adolescent development Ketamine treatment response prediction using EEG complexity metrics Eating disorder neurobiology through cognitive and emotional processing Analysis of his 14 most recent publications (2020-2025) reveals sophisticated application of Bayesian statistics, linear regression, and multiscale entropy analysis to neuroimaging data. His work frequently leverages the LEISURE study cohort examining brain-behavior relationships in aging populations. A significant portion investigates hemispheric asymmetry in neurodegenerative diseases and the neurophysiological underpinnings of mental health conditions. Currently active in the "Early brain functional changes in the Alzheimer's disease continuum" project (since August 2023), Anijärv works under Professor Oskar Hansson's supervision. This project appears integral to his doctoral thesis work, connecting EEG biomarkers with early Alzheimer's pathology.

Jean Margaret Addingtonمشاهده پروفایل

استاد

• Mental Health
• Schizophrenia and other psychoses
• Risk of developing serious mental illness
• +۳ مورد دیگر

Dr. Jean Margaret Addington is Professor of Psychiatry at the Cumming School of Medicine, University of Calgary, where she holds the Novartis Chair in Schizophrenia Research. She is also an Adjunct Professor in the Faculty of Arts, Department of Psychology, and is affiliated with multiple research institutes including the Hotchkiss Brain Institute, Alberta Children's Hospital Research Institute, and the Mathison Centre for Mental Health Research and Education. Dr. Addington's primary research focuses on psychosis and the risk of developing psychosis, with three main areas: 1) examining young people at clinical high risk of developing psychosis to develop prediction models; 2) conducting clinical trials testing treatments that may prevent or delay psychosis onset; and 3) studying transdiagnostic staging models to identify youth at different risk stages for serious mental illness. Her work involves examining environmental, clinical, social risk factors, and biomarkers to predict who may be at risk and how best to intervene. Her research has led to significant contributions in early psychosis intervention, including founding the Early Psychosis Program in Calgary and helping establish the Prevention through Risk Identification, Management and Prevention (PRIME) clinics in Calgary and Toronto. Current major projects include ProNET (Psychosis Risk Outcome Network), UPLIFT (a family intervention trial), The Stepped Care Project, and PROCAN (Canadian Psychiatric Risk and Outcome Study). Fellow, Royal Society of Canada (RSC), 2020 Richard J. Wyatt Award, IEPA Early Intervention in Mental Health, 2020 Fellow, Canadian Academy of Health Sciences (CAHS), 2019 Distinguished Service Award, Schizophrenia International Research Society (SIRS), 2019 Alberta Heritage for Medical Research Health Scientist, 2010 Alberta Centennial Addiction and Mental Health Research Chair, 2008 As Principal Investigator in all three phases of the NIMH-funded North American Prodromal Longitudinal Study (NAPLS-1, NAPLS-2, NAPLS-3) from 2005 to 2020, Dr. Addington has contributed significantly to understanding the predictors and mechanisms of transition to psychosis. Her research platform, the At-Risk for Mental Illness Research Clinic, continues to advance precision health approaches for youth mental health.

• Speech Therapy
• Autism Spectrum Disorders
• Childhood Behavioral Disorders
• +۵ مورد دیگر

Associate Professor Margarita Stankova is a faculty member in the Department of Healthcare and Social Work at New Bulgarian University's Faculty of Public Health. She holds dual expertise as a medical doctor (Sofia Medical University, 1997) and specialist in Communication Disorders (NBU, 2000), with additional qualifications in Psychiatry (2007). Her academic profile spans teaching 15+ specialized courses including Autism Spectrum Disorders , Fluency Disorders , and Clinical Psychology of Developmental Disorders . Education: Medicine, Sofia Medical University (1991-1997) Master's in Communication Disorders, New Bulgarian University (1997-2000) MD in Medicine (2006) Psychiatry Specialization (2007) Her research focuses on evidence-based interventions for communication disorders, particularly autism spectrum conditions and childhood behavioral/emotional disorders. Current work emphasizes digital therapeutic approaches including serious games and telepractice, with recent studies examining screen time impacts on ASD communication development and parent-mediated interventions. Her methodology integrates temperament profiling with neurocognitive assessment to develop individualized therapy protocols. Over the past decade, her publication trends reveal increasing specialization in ASD interventions (65% of recent work), digital health applications (25%), and cross-cultural assessment tools (10%). Key contributions include validating the Bulgarian FOCUS assessment and developing parent-administered digital screening tools. Research Leadership: Led 12+ EU-funded projects including "Early Intervention Program for Language Abilities" (Research Council of Norway) Principal investigator for "Integration of Children with Communication Disorders" (ESF) Coordinator of "Special Abilities and Talents" Erasmus intensive program Her clinical projects have established communication rehabilitation frameworks implemented across Bulgaria's day centers and specialized schools. Current work focuses on adapting evidence-based practices for post-pandemic therapeutic environments, with emphasis on parental support systems and digital integration. Laboratory & Field Work: Directs NBU's Communication Disorders Research Group conducting longitudinal studies on temperament profiles in developmental disorders. Field partnerships include specialized schools in Sofia, Stara Zagora, and Sandanski where therapeutic protocols are implemented and evaluated.

• Cognitive Psychology
• Developmental Psychology
• Lifespan Development
• +۶ مورد دیگر

Ralf Krampe is a Professor at the Faculty of Psychology and Educational Sciences at KU Leuven, where he leads research in the Laboratory for Experimental Psychology. He is also a member of the KU Leuven Brain Institute and serves as Program Director for the Master of Psychology: Theory and Research program. His academic leadership extends to multiple committees including the PPW Faculty Council, Faculty Doctoral Committee for Psychology and Educational Sciences, and various Programma- en Onderwijscommissies (POCs) for undergraduate and graduate psychology and educational sciences programs. Professor Krampe's research focuses on the cognitive and sensorimotor interactions across the lifespan , with particular emphasis on multitasking abilities and their developmental trajectories. His work investigates how cognitive and motor functions integrate during dual-task performance, especially examining postural control in relation to cognitive demands like listening or speech identification. A distinctive aspect of his research explores how expertise in specific domains (such as music or sports) influences cognitive-motor integration and may mitigate age-related declines. His studies span diverse populations including typically developing individuals across the lifespan, those with intellectual disabilities, and elite athletes. Analysis of Professor Krampe's recent publications (2023-2025) reveals consistent research themes centered on multitasking across the lifespan with increasing methodological sophistication. His work demonstrates strong interdisciplinary connections between cognitive psychology, neuroscience, kinesiology, and audiology. Recent publications show growing attention to training interventions aimed at improving cognitive-motor integration, particularly for aging populations, and examining how expertise in specific domains affects general cognitive processing. His research increasingly incorporates real-world contexts to enhance ecological validity of findings. Professor Krampe has secured substantial research funding for multiple projects extending through 2024, including studies on neuropsychological processes underlying expertise and multitasking (2022-2023), age-related changes in multitasking with respect to postural control (2019-2024), and understanding and improving listening as multitasking (2019-2024). His supervisory role is evident in numerous doctoral projects where he serves as promoter or co-promoter, particularly in areas related to cognitive-motor dual-task performance and rhythm perception. As Program Director of the Master of Psychology: Theory and Research program and through his teaching of advanced courses including Topics in Lifespan Developmental Psychology and Neurocognitive Development over the Lifespan, Professor Krampe plays a significant role in shaping psychological research methodology. His laboratory within the Laboratory for Experimental Psychology and the Brain Institute provides a collaborative environment for investigating the neural and cognitive mechanisms underlying human performance across the lifespan, with particular attention to how these processes change with age and experience.

Beverly S. Emanuelمشاهده پروفایل

استاد

• Genetics
• Pediatrics
• Human Genetics
• +۳ مورد دیگر

Beverly S. Emanuel, PhD is the Charles E.H. Upham Professor of Pediatrics in the Department of Pediatrics at the University of Pennsylvania's Perelman School of Medicine. She specializes in Human Genetics within the Division of Human Genetics at Children's Hospital of Philadelphia (CHOP), where she maintains her laboratory in the ARC Building. Dr. Emanuel has dedicated her career to understanding chromosomal abnormalities, particularly those involving chromosome 22. Dr. Emanuel's research focuses on the genetic basis of DiGeorge Syndrome (DGS) and Velocardiofacial Syndrome (VCFS), with her laboratory having identified that most patients with these conditions carry a deletion in the same region of chromosome 22. Her team developed the standard diagnostic test used worldwide to assess 22q11.2 deletions and recurrence risks. Current research examines molecular mechanisms of deletion and translocation breakpoints, particularly the t(11;22)(q23;q11) translocation, using techniques including fluorescence in situ hybridization, PCR, Southern blot, and pulsed-field gel electrophoresis. Her extensive publication record shows consistent productivity through 2025, with research spanning molecular genetics, clinical manifestations of 22q11.2 deletion syndrome, neurocognitive aspects, and structural genomic mechanisms. Recent work has expanded to include proteomic analyses, neuroimaging studies, and investigations of population-specific genomic architecture affecting 22q11.2 deletion mechanisms. Diplomate of the American Board of Medical Genetics as a Clinical Cytogeneticist (1981) Diplomate of the American Board of Medical Genetics as a Ph.D. Medical Geneticist (1981) Charles E.H. Upham Professorship in Pediatrics Dr. Emanuel has mentored numerous students and collaborators through the Genomics and Computational Biology Graduate Group at UPenn. Her research has been supported by continuous funding from the National Institutes of Health and other organizations, enabling her laboratory to maintain cutting-edge genomic technologies. She leads collaborative studies on 22q11.2 deletion syndrome through the International 22q11.2 Brain and Behavior Consortium, facilitating large-scale international research efforts. Her laboratory at CHOP's Joseph Stokes Jr. Research Institute serves as a hub for 22q11.2 deletion syndrome research, bringing together geneticists, clinicians, neuroscientists, and computational biologists to investigate the molecular mechanisms and clinical manifestations of this complex genomic disorder.

Perminder Singh Sachdevمشاهده پروفایل

استاد

• Neuropsychiatry
• Dementia
• Alzheimer's Disease
• +۷ مورد دیگر

Scientia Professor Perminder Singh Sachdev AM, MBBS, MD, PhD, FRANZCP, FAAHMS serves as Professor of Neuropsychiatry at UNSW Sydney, Co-Director of the Centre for Healthy Brain Ageing (CHeBA), and Clinical Director of the Neuropsychiatric Institute at Prince of Wales Hospital in Sydney, Australia. His distinguished career spans multiple leadership roles including past-president of the International Neuropsychiatric Association and inaugural Chair of the Section of Neuropsychiatry of the Royal Australian and New Zealand College of Psychiatrists. Professor Sachdev completed his medical education at the All-India Institute of Medical Sciences, New Delhi (MBBS 1978), followed by an MD in Psychiatry (1983) at the same institution. He furthered his training in New Zealand and Australia, where he earned his PhD in 1991 with research focused on ethnopsychological concepts in Maori culture. His academic journey culminated in numerous professional qualifications including FRANZCP and FAAHMS. His research spans multiple critical areas in neuropsychiatry and aging, with particular emphasis on dementia and pre-dementia syndromes. His work integrates neuroimaging, neuropsychology, biomarkers, and risk factors to advance understanding of cognitive decline. Early in his career, he made significant contributions to understanding drug-induced movement disorders including akathisia, tardive dyskinesia, and neuroleptic malignant syndrome. More recently, his research has expanded to include brain stimulation techniques (TMS, DCS, VNS, and DBS) for psychiatric disorders. His work bridges clinical practice with population-based research through major longitudinal studies. Analysis of his recent publications reveals a strong focus on neuroimaging biomarkers for Alzheimer's disease, cognitive reserve mechanisms, genetic risk factors for dementia, and innovative interventions including transcranial magnetic stimulation. His work demonstrates consistent integration of clinical observations with rigorous scientific methodology across multiple disciplines including neuroscience, geriatrics, and neurogenetics. NSW Scientist of the Year for Biomedical Sciences (2010) Appointed Member of the Order of Australia (2011) Founder's Medal by the Australian Society for Psychiatric Research (2011) International Distinguished Fellow of the American Psychiatric Association (2012) UNSW Medicine Dean's award for outstanding contribution to research and teaching (2014) Fellow of the Australian Academy of Health and Medical Sciences (2015) Professor Sachdev has secured substantial funding to support his research programs, including leadership of three major longitudinal cognitive aging studies: Sydney Memory and Ageing Study, Older Australian Twins Study, and Sydney Centenarian Study. He also leads three international networks: COSMIC, STROKOG, and ICC-Dementia. His research has been supported by numerous grants from national and international funding bodies focused on brain health and dementia prevention. Beyond his formal academic roles, he serves as Chief Medical Adviser to Alzheimer's Australia and Medical Adviser to the Tourette Syndrome Association of Australia. The Centre for Healthy Brain Ageing (CHeBA), which Professor Sachdev co-founded in 2012, represents a major interdisciplinary research hub focused on promoting brain health and preventing dementia. CHeBA brings together researchers from diverse fields including neuroscience, psychology, genetics, and public health to address the complex challenges of cognitive aging. The institute maintains strong collaborations with clinical services at Prince of Wales Hospital through the Neuropsychiatric Institute, creating a seamless research-clinical interface.

• Neurology
• Pharmacology
• Mental Health
• +۴ مورد دیگر

Jacques-Yves Montplaisir is a Full Professor in the Department of Psychiatry and Addictology at the University of Montreal's Faculty of Medicine. He serves as Director of the Center for Advanced Research in Sleep Medicine (CÉAMS) and holds the Canada Research Chair in Sleep Medicine. His work spans clinical, epidemiological, and neurophysiological research in sleep disorders. His educational background includes foundational work under Dr. Herbert Jasper at the Department of Physiology (1972) and research at Caltech with James Olds. He founded Canada's first sleep research center at Hôpital du Sacré-Coeur de Montréal in 1977 and has directed multiple research initiatives including the Fernand-Seguin Research Center. Neurological basis of sleep and circadian rhythms Pathophysiology and treatment of sleep disorders Biomarkers of Alzheimer's disease Longitudinal pediatric sleep studies Clinical pharmacology of sleep medications His research output shows consistent focus on REM sleep behavior disorder, sleepwalking, restless legs syndrome, and connections between sleep disorders and neurodegenerative conditions. Recent work increasingly examines sleep's role in cognitive impairment and dementia. Prix Léo-Pariseau (2004) Prix Wilder-Penfield (2007) Lifetime Contribution Award (World Sleep Federation, 2011) Ordre national du Québec (2017) Dr. Montplaisir has supervised over 20 graduate students across neuroscience, psychiatry, and sleep medicine disciplines. His research has been continuously funded for over 30 years by CIHR/IRSC, with major grants including a $5 million infrastructure grant from the Canadian Foundation for Innovation in 2006. He leads multiple large-scale research networks including the Canadian Sleep and Circadian Network. He directs the Center for Advanced Research in Sleep Medicine (CÉAMS) and collaborates extensively with the CIUSSS Nord-de-l'île-de-Montréal – Hôpital du Sacré-Cœur de Montréal. His work bridges clinical practice, research infrastructure development, and pharmaceutical industry collaboration.

Richard Daviesمشاهده پروفایل

مدرس

• Assistive Technologies
• Stroke Rehabilitation
• Wearable Technology
• +۵ مورد دیگر

Richard Davies is a Lecturer in Computing Science at Ulster University's Faculty of Computing, Engineering and the Built Environment. He joined the School of Computing and Mathematics in 2001 as a Research Assistant and was appointed Lecturer in Computer Science in 2013. His work is aligned with the Smart Environment Research Group (SERG) where he focuses on developing technologies to support independent living and assistive technologies. His primary research interests center on assistive technologies for chronic conditions including stroke, chronic pain, congestive heart failure, COPD, and dementia. Dr. Davies specializes in wearable technology applications for stroke rehabilitation and has extensive experience designing systems that support independent living for aging populations. His work bridges computer science, healthcare, and rehabilitation engineering to create practical solutions for real-world challenges. His recent publications demonstrate a strong focus on wearable sensor technology, particularly smart insoles and gait analysis systems for rehabilitation settings. The research consistently addresses home-based rehabilitation, remote monitoring, and technology solutions for healthcare system challenges. His work has significant implications for elderly care, stroke recovery, and chronic disease management. Dr. Davies is an active member of the engineering community, having served on panels including Engineers Ireland Accreditation panel and conferences such as ICOST2012, CinC 2010, and IEEE BIBM. He has co-chaired workshops on Assistive Technology and continues to contribute to the field through collaborative research projects. He is currently pursuing a PhD within the School of Computing and Mathematics focused on improving post-stroke rehabilitation through assistive/wearable technology. His educational background includes a BEng(Hons) in Electronic Systems from Ulster University, providing him with a strong foundation for his interdisciplinary work in health technology.

• Exposure Assessment Using GIS and Environmental Modeling
• Historical Exposure Characterization
• Improving Water and Sanitation Interventions
• +۷ مورد دیگر

James A. VanDerslice, PhD, is a Professor in the Division of Public Health, focusing on environmental epidemiology and exposure assessment. His research spans chemical and microbiological hazards, with emphasis on GIS and environmental modeling to study spatial patterns. Doctoral Training: University of North Carolina, School of Public Health Postdoctoral Fellowship: University of North Carolina MSEE: University of North Carolina BSEE: Humboldt State University Research interests include: Drinking water quality and health impacts Antimicrobial resistance transmission via fecal-oral routes Built environment effects on physical activity and obesity Air pollution and diverse health outcomes (suicide, pneumonia, cancer) Recent publications analyze PM2.5 effects on intellectual disability, airborne lead exposure in children, and antimicrobial resistance in Pakistani healthcare facilities. His work integrates geospatial analysis, environmental modeling, and health equity frameworks.

Lisa Wruckمشاهده پروفایل

استاد

• Biostatistics
• Bioinformatics
• Pragmatic Clinical Trials
• +۵ مورد دیگر

Lisa Wruck is a Professor of Biostatistics & Bioinformatics at Duke University School of Medicine and a Member of the Duke Clinical Research Institute. Her work focuses on the design and analysis of pragmatic clinical trials, real-world evidence generation, and neurocognitive data, with applications in cardiovascular disease, stroke, and health disparities. Her educational background: Ph.D., Harvard University, T.H. Chan School of Public Health (2004) Dr. Wruck's research program centers on biostatistics and bioinformatics, with a strong emphasis on pragmatic clinical research and real-world evidence. She investigates the impact of social determinants of health on cognitive outcomes and cardiovascular disease, and is actively involved in data science workforce development initiatives to train the next generation of researchers. Her primary research interests include: Pragmatic Clinical Trials Real World Evidence Neurocognitive Data Analysis Data Science Workforce Development Cardiovascular Disease Epidemiology Stroke and Dementia Outcomes Her recent publications (2024-2025) demonstrate a consistent focus on cardiovascular outcomes, stroke, and dementia, often leveraging large pragmatic trials such as ADAPTABLE. Key themes include aspirin dosing strategies, racial and gender disparities in treatment outcomes, and the application of advanced statistical methods to real-world data for regulatory decision-making. Scientific awards: None mentioned. Dr. Wruck has secured substantial grant funding from diverse sources including the National Institutes of Health (NIH), industry partners (Bristol-Myers/Sanofi, Baxter), and academic institutions. Notable projects include: The Gut Brain Parkinson's Disease Consortium (2024-2029) RADx-UP CDCC (2020-2025) ADAPTABLE trial analyses (multiple grants) Her role as a professor involves mentoring graduate students and postdoctoral fellows in biostatistics and clinical research, though specific advisees were not listed in the provided text. She is actively involved in the Duke Clinical Research Institute and leads coordinating centers for multi-site studies, fostering collaborative research teams across institutions.